单位:[a]Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China首都医科大学附属北京儿童医院[b]Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China[c]School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, China[d]Key Laboratory of Molecular Pharmaceutics, New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China[e]School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China[f]Department of Gastrointestinal Surgery, China-Japan Friendship Hospital, Beijing, 100029, China
Chemotherapy post cancer surgery has important clinical significance for reducing the chance of recurrent-metastasis. However, postoperative chemotherapy efficacy is hampered by poor targeting capability and dose-limiting toxicity of chemo-drugs. Herein, we report a bio-mimetic platelet membrane-cloaked paclitaxel nano-crystal system (PPNCs), which consists of spherical paclitaxel nanocrystals (PNCs) as a high-dose drug core, polyethylene glycol-conjugated paclitaxel (PEG-PTX) as an amphiphilic molecule to adjust the surface hydrophilicity of PNCs and the shell of platelet membrane that can target surgical coagulation site. The in vitro characterization of PPNCs exhibited uniform particle size distribution, high drug loading, and good stability, which are crucial for effective drug delivery. At cell levels, PPNCs showed greater cellular uptake and higher cytotoxicity in 4T1 breast cancer cells than bare PNCs. In vivo, the nanoparticles could deliver high-dose chemodrugs and target the coagulation site caused by surgery or vascular disrupting agents, resulting in enhanced antitumor efficacy and reduced systemic toxicities. In general, the PPNCs system can be served as a promising and efficient drug delivery system for postoperative chemotherapy.
基金:
National Natural Science Foundation of China, ChinaNational Natural Science Foundation of China (NSFC) [81903545]; Fundamental Research Funds for the Central Universities, ChinaFundamental Research Funds for the Central Universities [BMU2017YJ001]; Beijing Natural Science Foundation, ChinaBeijing Natural Science Foundation [7204261]; National Major Science and Technology Projects of China, China [2018ZX09721003]
第一作者单位:[a]Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China
通讯作者:
推荐引用方式(GB/T 7714):
Mei D,Gong L,Zou Y,et al.Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy[J].JOURNAL of CONTROLLED RELEASE.2020,324:341-353.doi:10.1016/j.jconrel.2020.05.016.